Jonathan R. Volpatti
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy.
Journal: The Journal of clinical investigation
Published: October 13, 2022
Variants in CLDN5 cause a syndrome characterized by seizures, microcephaly and brain calcifications.
Variants in CLDN5 cause a syndrome characterized by seizures, microcephaly and brain calcifications.
Journal: Brain : a journal of neurology
Published: June 28, 2022
Egg-laying and locomotory screens with C. elegans yield a nematode-selective small molecule stimulator of neurotransmitter release.
Journal: Communications biology
Published: May 16, 2022
X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition.
Journal: Acta neuropathologica
Published: March 02, 2022
Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy.
Journal: Disease models & mechanisms
Published: December 22, 2021
Natural history of a mouse model of X-linked myotubular myopathy.
Journal: Disease models & mechanisms
Published: October 11, 2021
Selective control of parasitic nematodes using bioactivated nematicides.
Journal: Nature
Published: May 18, 2021
Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.
Journal: Human molecular genetics
Published: September 10, 2019
The expanding spectrum of neurological disorders of phosphoinositide metabolism.
Journal: Disease models & mechanisms
Published: August 16, 2019
Signs and Symptoms in Congenital Myopathies.
Journal: Seminars in pediatric neurology
Published: May 08, 2019
PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models.
Journal: The Journal of clinical investigation
Published: February 01, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026